[Bloodstream Candida infections].
Nosocomial Candida infection is an everincreasing cause of morbidity, mortality and prolonged hospitalization of the patients in intensive care units. The increase of the candidiasis cases is due to growing population of immunocompromised patients and the use of new, aggressive, and invasive therapeutic strategies. Some manifestations of Candida albicans infections are associated with formation of biofilms on the surface of biomaterials. The incidence, epidemiology, clinical characteristics and treatment of Candida bloodstream infections are surveyed.
Izvekova
I Ia
IIa
D000935:Antifungal Agents / Q000627:therapeutic use; D018441:Biofilms; D002175:Candida / Q000502:physiology*; D002177:Candidiasis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D002405:Catheterization, Central Venous; D002408:Catheters, Indwelling / Q000382:microbiology; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D025141:Drug Resistance, Fungal; D016469:Fungemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans
D000935:Antifungal Agents